cholecystectomy and glp 1 GLP-1 After Gallbladder Removal | Safety Guide Side Effect Profile of GLP-1
Description
Effective January 1, 2026, Medi-Cal Rx is excluding coverage for GLP-1 medications prescribed for weight loss: [12] Wegovy, Zepbound, Saxenda: Completely removed from the Contract Drugs List for weight loss Ozempic, Mounjaro, Rybelsus: Restricted to Type 2 diabetes onlyweight loss claims will auto-deny Existing prior authorizations end December 31, 2025 Exceptions: Members under age 21 may still qualify via EPSDT Non-weight-loss indications (Zepbound for OSA, Wegovy for cardiovascular) may still get PA approval This does NOT affect Kaiser commercial or employer-sponsored plansonly Medi-Cal members
The compounded formulations are not FDA-approved, so the agency does not review the safety and efficacy of these products
Rapid weight loss changes your relationship with food in ways that can be psychologically destabilizing
The list goes on and on, so much so that its almost difficult to keep up with it
However, this should not be relied upon as a primary strategy for managing steroid-induced hyperglycaemia
